株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の創薬アウトソーシング市場の予測

Drug Discovery Outsourcing Market Forecast 2016-2026: Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening

発行 Visiongain Ltd 商品コード 260308
出版日 ページ情報 英文 232 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=147.80円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
世界の創薬アウトソーシング市場の予測 Drug Discovery Outsourcing Market Forecast 2016-2026: Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening
出版日: 2016年09月20日 ページ情報: 英文 232 Pages
概要

2016年における世界の創薬アウトソーシング市場の収益規模は192億ドルの規模に達すると予測されています。初期の創薬段階において製薬会社やバイオテクノロジー企業がCROと提携して開発に取り組む傾向が強まっています。

当レポートは、世界の創薬アウトソーシング市場の現状と見通しについて調査分析し、創薬業務をアウトソーシングする理由とメリット、主なCRO(受託臨床試験機関)のプロファイル、業務区分・地域/国別の収益予測、創薬アウトソーシングの成長推進因子・阻害因子の分析、専門家による見解、SWOT分析などをまとめてお届けいたします。

第1章 レポート概要

第2章 創薬アウトソーシング:イントロダクション

  • アウトソーシングとは?
  • 創薬アウトソーシングとは?
  • 創薬業務をアウトソーシングする理由
  • 創薬における典型的なアウトソーシングプロセス(産学協同を含む)
  • 創薬のアウトソースモデルが革新を増進
  • 創薬におけるアウトソーシングプロセス
  • 創薬のアウトソーシングにおける課題
  • CROに人気の新興市場
  • 買収に向けた戦略的提携
  • 最新の創薬業務委託契約
  • 創薬アウトソーシング関連用語集

第3章 世界の創薬アウトソーシング市場

  • 創薬アウトソーシング:世界市場の概要
  • 世界の創薬アウトソーシング市場の部門
  • 世界の創薬アウトソーシング市場:実績と予測(部門別)
  • 部門別の市場シェアの推移
  • 世界の化学関連サービスのアウトソーシング市場
    • ライブラリー化合物
    • 構成要素
    • 合成樹脂
    • 市場予測
  • 世界のバイオロジー関連サービスのアウトソーシング市場
    • 目標の識別
    • 目標の検証
    • 市場予測
  • 世界のリード最適化のアウトソーシング市場
    • 創薬ADMETスクリーニング
    • 世界のリード最適化市場
  • 世界のリード化合物の特定・スクリーニングのアウトソーシング市場
    • 創薬におけるスクリーニング手法
    • 一次スクリーニング
    • 市場予測

第4章 主要国市場

  • 創薬アウトソーシングの概要
  • 主要国市場:実績と予測
  • 市場シェア予測
  • CAGR予測
  • 米国:市場売上予測
  • EU5ヶ国:市場売上予測(地域別)
  • 日本:市場売上予測
  • 中国:市場売上予測
  • インド:市場売上予測
  • ブラジル:市場売上予測
  • ロシア:市場売上予測
  • 韓国:市場売上予測
  • メキシコ:市場売上予測
  • その他の国:市場売上予測

第5章 創薬サービスを提供する主要企業

  • 創薬アウトソーシング:分裂し、拡大する市場
  • 主要開発業務受託機関の特徴
  • 主要国の提供するサービス
  • Albany Molecular Research, Inc (AMRI)
  • Aptuit
  • Charles River Laboratories
  • Covance
  • Cyprotex
  • Domainex
  • Evotec
  • GenScript
  • Pharmaceutical Product Development (PPD)
  • Quintiles
  • Selcia
  • Viva Biotech
  • WIL Research Laboratories
  • WuXi AppTec

第6章 創薬アウトソーシング市場:定性分析

  • 市場成長促進因子および抑制因子
  • SWOT分析
  • 強み
  • 弱み
  • 機会
  • 脅威
  • ポーターのファイブフォース分析

第7章 専門家の見解

第8章 総論

  • 市場概要
  • リード最適化―最速成長部門
  • 新興市場の台頭
  • アライアンス・コラボレーションが引き続き
  • 終わりに

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHA0143

Where is the drug discovery outsourcing market heading? Visiongain's new report gives you revenue predictions for the drug discovery outsourcing market and its submarkets from 2016 to 2026, helping you stay ahead.

Visiongain's new 232-page report provides revenue forecasts to 2026 for the global drug discovery outsourcing market, four leading submarkets and 13 leading national markets. The report profiles 14 leading CROs providing drug discovery outsourcing, and includes revenue forecasts and analysis to 2026 for 6 of those companies. It also includes 3 interview transcripts with industry experts regarding the current developments and the drivers of growth in the drug discovery outsourcing market.

Besides revenue forecast to 2026, this report provides market shares, business outlooks, qualitative analyses (including SWOT and Porter's Five Forces Analysis), company profiles and commercial partnerships.

See revenue forecasts for leading drug discovery outsourcing sectors

Along with prediction of overall world market value to 2026, our report shows you revenue forecasting for the four services sectors at world level:

  • Chemistry services market forecast 2016-2026
  • Biology services market forecast 2016-2026
  • Lead optimisation market forecast 2016-2026
  • Lead identification and screening market forecast 2016-2026

The analysis helps you identify market potential with individual revenue forecasts, annual growth rates and CAGRs and market shares.

Discover prospects of the leading national markets for the drug discovery outsourcing

The drug discovery outsourcing market is becoming increasingly global as companies look to lower costs by off-shoring their work to CROs based in emerging economies.

You will discover individual revenue forecasts, annual growth rates, CAGRs, and market shares to 2026, as well as written supporting analyses for each of the 13 leading national markets and the rest of the world (RoW) :

  • US
  • Japan
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • China
  • Brazil
  • Russia
  • India
  • South Korea
  • Mexico
  • Rest of the World

Demand for CROs based in emerging markets will be a major driver of growth in this market.

image1

Leading companies and potential for market growth

Our new study predicts the world market for drug discovery outsourcing will reach $19.2bn in 2016. There is the increasing trend for pharmaceutical and biotech companies to form partnerships and alliances with CROs during the early drug discovery phase.

Our research profiles leading companies, assessing their financial performance and products. You will see which organisations hold the greatest potential and what services each offer. See the profiles of 14 leading companies:

  • Albany Molecular Research (AMRI)
  • Aptuit
  • Charles River Laboratories
  • Covance
  • Cyprotex
  • Domainex
  • Evotec
  • GenScript
  • Pharmaceutical Product Development (PPD)
  • Quintiles
  • Selcia
  • Viva Biotech
  • WIL Research Laboratories
  • WuXi AppTec

Table of Contents

1. Report Overview

  • 1.1 The Drug Discovery Outsourcing Market Overview
  • 1.2 Drug Discovery Outsourcing Market Segmentation
  • 1.3 Why You Should Read This Report
  • 1.4 How This Report Delivers
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report For?
  • 1.7 Methodology
  • 1.8 Frequently Asked Questions (FAQ)
  • 1.9 Associated Reports

2. An Introduction to Drug Discovery Outsourcing

  • 2.1 What is Outsourcing?
  • 2.2 What is Drug Discovery Outsourcing?
  • 2.3 Why Outsource Drug Discovery?
  • 2.4 A Common Drug Discovery Model Includes Pharmaceutical Organizations Collaborating with Academia
  • 2.5 The Outsource Model for Drug Development Increases Innovation
  • 2.6 Outsourced Processes in Drug Discovery
  • 2.7 Challenges with Drug Discovery Outsourcing
  • 2.8 Emerging Markets are a Popular Destination for CROs
  • 2.9 Strategic Partnerships to Acquisitions
  • 2.10 Recent Drug Development Outsourcing Agreements
  • 2.11 Glossary of Terms Related to Drug Discovery Outsourcing

3. Global Drug Discovery Outsourcing Market and Service Area Submarkets, 2016-2026

  • 3.1 Drug Discovery Outsourcing: Global Market Overview
  • 3.2 The Global Drug Discovery Outsourcing Market Sectors
  • 3.3 The Global Drug Discovery Outsourcing Market by Sector, 2015
  • 3.4 The Global Drug Discovery Outsourcing Market by Sector, 2015-2026
  • 3.5 The Changing Market Shares by Sector, 2015-2026
  • 3.6 The Global Chemistry Services Outsourcing Market, 2015
    • 3.6.1 Libraries
    • 3.6.2 Building Blocks
    • 3.6.3 Compound Synthesis
    • 3.6.4 The Global Chemistry Services Outsourcing Market Forecast, 2015-2026
  • 3.7 The Global Biology Services Outsourcing Market, 2015
    • 3.7.1 Target Identification
    • 3.7.2 Target Validation
    • 3.7.3 The Global Biology Services Outsourcing Market Forecast, 2015-2026
  • 3.8 The Global Lead Optimisation Market, 2015
    • 3.8.1 ADMET Screening: Prevents Late Stage Failure of Clinical Trials
    • 3.8.2 The Global Lead Optimisation Market Forecast, 2015-2026
  • 3.9 The Global Lead Identification and Screening Outsourcing Market, 2015
    • 3.9.1 Methods of Screening in Drug Discovery
    • 3.9.2 Primary Screening
    • 3.9.3 The Global Lead Identification and Screening Outsourcing Market Forecast, 2015-2026

4. The Leading National Markets in the Drug Discovery Outsourcing Market 2015-2026

  • 4.1 Drug Discovery Outsourcing Overview
  • 4.2 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015
  • 4.3 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
  • 4.4 The Changing Market Shares of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
  • 4.5 CAGRs of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
  • 4.6 The US Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
  • 4.7 The EU5 Drug Discovery Outsourcing Market by Region, 2015
    • 4.7.1 The EU5 Drug Discovery Outsourcing Market Forecast, 2015-2026
    • 4.7.2 CAGRs by EU5 Region, 2015-2026
    • 4.7.3 The EU5 Changing Market Shares by Country 2015-2026
      • 4.7.3.1 The German Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
      • 4.7.3.2 The UK Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
      • 4.7.3.3 The French Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
      • 4.7.3.4 The Italian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
      • 4.7.3.5 The Spanish Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
  • 4.8 The Japanese Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
  • 4.9 The Chinese Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
    • 4.9.1 Challenges to China's Growth
  • 4.10 The Indian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
  • 4.11 The Brazilian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
  • 4.12 The Russian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
  • 4.13 The South Korean Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
  • 4.14 The Mexican Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
  • 4.15 The Rest of the World Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

5. Leading Companies in the Drug Discovery Outsourcing Market

  • 5.1 Drug Discovery Outsourcing: A Fragmented and Growing Marketplace
  • 5.2 Characteristics of Leading Contract Research Organisations
    • 5.2.1 A Highly Quality Workforce
    • 5.2.2 Emphasis on Intellectual Property Protection
    • 5.2.3 Long Term Working Relationship
    • 5.2.4 Success in Project Completion
    • 5.2.5 Internal Drug Discovery Programmes
  • 5.3 Service Offerings of Leading Companies in the Drug Discovery Outsourcing Market
  • 5.4 Albany Molecular Research (AMRI)
    • 5.4.1 Historical Sales and Recent Financial Performance, 2011-2014
    • 5.4.2 AMRI's Drug Discovery Services
    • 5.4.3 Internal Portfolio of Drug Discovery and Development Programme Collaborations
    • 5.4.4 AMRI (DDS) Sales Forecast, 2015-2026
  • 5.5 Aptuit
    • 5.5.1 INDIGO: Accelerating Early Drug Candidates
    • 5.5.2 Aptuit Clinical Trial Supplies
    • 5.5.3 Strategic Partnerships, Acquisitions and Divestitures
      • 5.5.3.1 Divestiture of Aseptic Clinical Manufacturing
      • 5.5.3.2 Aptuit's Extended Partnership with GSK for VeronaCentre
      • 5.5.3.3 Partnership with Siena Biotech
      • 5.5.3.4 Partnership with Laurus Labs
  • 5.6 Charles River Laboratories
    • 5.6.1 Sales and Historical Financial Performance, 2011-2014
    • 5.6.2 Charles River Laboratories: An External Acquisition Strategy
      • 5.6.2.1 Acquisition of ChanTest
      • 5.6.2.2 Acquisition of Galapagos' CRO Services Division (BioFocus and Argenta)
      • 5.6.2.3 Acquisition of VivoPath
    • 5.6.3 Charles River Laboratories: Revenue and Financial Analysis, 2014
    • 5.6.3.1 Charles River Laboratories: Historical Financial Performance by Business Segment, 2013-2014
    • 5.6.4 Charles River Laboratories Sales Forecast, 2015-2026
  • 5.7 Covance (Acquired by Laboratory Corporation of America)
    • 5.7.1 Covance: Historical Revenue and Financial Performance, 2010-2013
    • 5.7.2 Covance: Early Stage Discovery Efforts
    • 5.7.3 Agreement with Sanofi
    • 5.7.4 Agreement with Kellogg Company
    • 5.7.5 Agreement with Bio Pontis Alliance
    • 5.7.6 Agreement with Indiana Clinical and Translational Sciences Institute (CTSI)
    • 5.7.7 Agreement with EliLilly
  • 5.8 Cyprotex
    • 5.8.1 Historical Revenue and Financial Performance, 2011-2014
    • 5.8.2 Cyprotex: Revenue by Region, 2015
    • 5.8.3 Cyprotex: Revenue Analysis and Forecast 2015-2026
  • 5.9 Domainex
    • 5.9.1 Drug Pipeline
    • 5.9.2 TBK1/ IKKεInhibitors
    • 5.9.3 Methyltransferase (KMTS) Inhibitors
  • 5.10 Evotec
    • 5.10.1 Strategic Action Plan
    • 5.10.2 Evotec: Historical Revenue and Financial Analysis, 2010-2014
    • 5.10.3 EVT Integrate and EVT Innovate
    • 5.10.4 Partnerships with Pharma for Drug Discovery
      • 5.10.4.1 Partnership with Sanofi
      • 5.10.4.2 Extended Partnership with Evotec
      • 5.10.4.3 Partnership with Johnson & Johnson
      • 5.10.4.4 Partnership with AstraZeneca
      • 5.10.4.5 Partnership with Bayer Pharmaceuticals
      • 5.10.4.6 Partnership with Boehringer Ingelheim Pharma
      • 5.10.4.7 Collaboration with CHDI
      • 5.10.4.8 Collaboration with Janssen
      • 5.10.4.9 Collaboration with MedImmune
      • 5.10.4.10 Collaboration with UCBPharma
    • 5.10.5 Evotec Sales Forecast, 2015-2026
  • 5.11 GenScript
    • 5.11.1 GenScript: Agreements and Partnerships
  • 5.12 Pharmaceutical Product Development (PPD)
    • 5.12.1 PPD: Agreements, Strategic Partnerships and Private Merger
      • 5.12.1.1 Acquisition of Acurian
      • 5.12.1.2 Partnership with Elan
      • 5.12.1.3 Partnership with GSK
  • 5.13 Quintiles
    • 5.13.1 Quintiles: Historical Revenue and Financial Performance, 2009-2014
    • 5.13.2 Development Deal With Merck
    • 5.13.3 Quintiles: Acquisition of Advion Bioanalytical Labs
    • 5.13.4 Quintiles: SheddingJobs
    • 5.13.5 Quintiles Sales Forecast, 2015-2026
  • 5.14 Selcia
    • 5.14.1 A Strong Natural Product Chemistry Track Record
    • 5.14.2 Initiative with the University of Edinburgh
    • 5.14.3 Collaboration with Cantab
  • 5.15 Viva Biotech
    • 5.15.1 GPCR Targeted Discovery Programs
    • 5.15.2 Antibody Therapeutics Discovery
  • 5.16 WIL Research Laboratories
    • 5.16.1 Focus on Preclinical Research
    • 5.16.2 Acquisition of Ricerca Biosciences LLC
    • 5.16.3 Acquisition of Midwest Bio Research
  • 5.17 WuXi Apptec
    • 5.17.1 WuXi AppTec: Service Offerings
    • 5.17.2 Acquisition of Next CODE Health
    • 5.17.3 WuXiAppTec: Historical Revenue and Financial Performance, 2010-2014
    • 5.17.4 WuXiAppTec: Laboratory Services Sales Forecast, 2015-2026

6. Quantitative Analysis of the Drug Discovery Outsourcing Market, 2016-2026

  • 6.1 Drivers and Restraints in the Drug Discovery Outsourcing Market, 2016-2026
  • 6.2 SWOT Analysis of the Drug Discovery Outsourcing Market, 2016-2026
  • 6.3 Strengths
    • 6.3.1 Cost Reduction: A Central Driver for Outsourcing
    • 6.3.2 Accelerating the Discovery of Drug Candidates
    • 6.3.3 Growth of Virtual Pharmaceutical Companies
    • 6.3.4 Reduction in R&D capacity Within Big Pharma
  • 6.4 Weaknesses
    • 6.4.1 Slowing Trajectory of Growth for R&D Spending
    • 6.4.2 Increasingly Saturated Market Requires Companies to Quickly Evolve
  • 6.5 Opportunities
    • 6.5.1 The Available Scope for the Expansion of CROs
    • 6.5.2 Targeted Therapies: Advances in Biologics and Orphan Drugs
    • 6.5.3 Increasing Development of Biologics and Biosimilars
  • 6.6 Threats
    • 6.6.1 A Competitive Market is Increasing Consolidation
    • 6.6.2 Threat of Private Public Alliances
    • 6.6.3 Intellectual Property Leaks
    • 6.6.4 Challenges of Technology Transfer
  • 6.7 Porter's Five Force Analysis of the Drug Discovery Outsourcing Market
    • 6.7.1 Threat of New Entrants: Medium
    • 6.7.2 Power of Suppliers: Medium
    • 6.7.3 Threat of Substitutes: Medium
    • 6.7.4 Power of Buyers: High
    • 6.7.5 Rivalry Among Competitors: High

7. Expert Opinions

  • 7.1 Interview with Dr. Mario Polywka, Chief Operating Officer, Evotec
    • 7.1.1 Bridging the Gap Between Academia and BigPharma
    • 7.1.2 Evotec: Specialises in Certain Disease Therapies
    • 7.1.3 Complete Drug Discovery Outsourcing: A Growing Trend
    • 7.1.4 Strategies for Drug Discovery Outsourcing Expansion
    • 7.1.5 Building Trust in Collaborations
    • 7.1.6 Evotec: Proven Track Record of Success
  • 7.2 Dr. John Davis, Director of Discovery and Dave Roberts, Business Development Director, Radiochemistry, Selcia
    • 7.2.1 Growth in the Full Spectrum of Outsourcing Services
    • 7.2.2 Natural Products: Increasing Source of Drug Discovery
    • 7.2.3 Strong Pool of Early Drug Candidates
    • 7.2.4 Overcoming Drug Discovery Challenges using Drug Discovery
    • 7.2.5 Selcia: Regional Base of Clients
    • 7.2.6 Drug Discovery and Emerging Technologies
    • 7.2.7 Med Chem Plus Projects
    • 7.2.8 Varied Customer Base
    • 7.2.9 CROs: Improving Drug Discovery Productivity Levels?
  • 7.3 Interview with Dr. Paul Overton, Executive VP, Business Development & Marketing, Aptuit
    • 7.3.1 End-to-End Drug Discovery Integration Growth
    • 7.3.2 Whole Project Externalisation
    • 7.3.3 Drug Discovery Outsourcing: One of Aptuit's Fastest Growing Services
    • 7.3.4 Aptuit INDiGO® Program
    • 7.3.5 Aptuit Implementation Drug Discovery Acquisitions
    • 7.3.6 Aptuit: Adding the Intellectual Capabilities for Drug Discovery
    • 7.3.7 Several Partners in the Drug Discovery Model

8. Conclusion

  • 8.1 Market Overview
  • 8.2 Lead Optimisation will be the Fastest Growing Sector
  • 8.3 The Drug Discovery Outsourcing Market in Emerging Market Shows Huge Gains
  • 8.4 Continued Growth in Alliances and Collaborations
  • 8.5 Concluding Remarks
  • AssociatedVisiongainReports
  • VisiongainReportSalesOrderForm
  • AppendixA
  • AboutVisiongain
  • AppendixB
  • Visiongain report evaluation form

List of Tables

  • Table 1.1 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 1.2 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 2.1 Indication of Functions Outsourced in the Different Stages of the Drug R&D Process, 2016
  • Table 2.2 Selected Drug Discovery Outsourcing Alliances, 2013-2016
  • Table 2.2 (Cont'd) Selected Drug Discovery Outsourcing Alliances, 2013-2016
  • Table 3.1 PhMRA's Historical Estimate for its Member's Total R&D Spending ($bn), 1980-2015
  • Table 3.2 The Global Drug Discovery Outsourcing Market: Revenue ($bn), Market Share (%) by Sector, 2015
  • Table 3.3 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026
  • Table 3.4 The Global Drug Discovery Outsourcing Market: Revenue Share (%) by Sector, 2015 , 2020 and 2026
  • Table 3.5 The Chemistry Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026
  • Table 3.6 The Biology Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026
  • Table 3.7 The Lead Optimisation Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026
  • Table 3.8 Selected Source for Lead Compounds, 2015
  • Table 3.9 The Lead Identification and Screening Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.1 The Global Drug Discovery Outsourcing Market: Revenue ($bn), Market Share (%) by Region, 2015
  • Table 4.2 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Region, 2015-2026
  • Table 4.2.1 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Region, 2015-2026
  • Table 4.3 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2015, 2020, 2026
  • Table 4.4 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2015-2020, 2020-2026, 2015-2026
  • Table 4.5 The US Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.6 The US Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.7 The EU5 Drug Discovery Outsourcing Market: Revenue ($bn), Market Share (%) by Region, 2015
  • Table 4.8 The EU5 Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.9 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2015-2020, 2020-2026, and 2015-2026
  • Table 4.10 The EU5 Drug Discovery Outsourcing Market: Market Shares (%) by Country, 2015, 2020, 2026
  • Table 4.11 The German Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.12 The German Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.13 The UK Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.14 The UK Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.15 The French Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.16 The French Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.17 The Italian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.18 The Italian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.19 The Spanish Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.20 The Spanish Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.21 The Japanese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.22 The Japanese Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.23 The Chinese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.24 The Chinese Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.25 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.26 The Indian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.27 The Brazilian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.28 The Brazilian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.29 The Russian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.30 The Russian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.31 The South Korean Drug Discovery Outsourcing MarketForecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.32 The South Korean Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.33 The Mexican Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 4.34 The Mexican Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
  • Table 4.35 The Rest of the World Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 5.1 Albany Molecular Research (AMRI): Historical Revenue ($m), 2011-2014
  • Table 5.2 AMRI: Service Offerings and Descriptions, 2015
  • Table 5.3 AMRI: Drug Discovery and Development Programmes and Project Stage, 2015
  • Table 5.4 AMRI (DDS) Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
  • Table 5.5 Aptuit: Services Offered and their Descriptions, 2015
  • Table 5.6 Charles River Laboratories: Services Offered by Segment, 2016
  • Table 5.7 Charles River Laboratories: Revenue ($m), AGR (%), 2011-2014
  • Table 5.8 Charles River Laboratories: Revenue ($m) by Segment, 2011-2014
  • Table 5.9 Charles River Laboratories: Revenue ($bn) by Business Segment, 2013-2014
  • Table 5.10 Charles River Laboratories Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
  • Table 5.11 Covance: Historical Revenue ($bn) by Business Segment, 2010-2013
  • Table 5.12 Selected Cyprotex Partnerships, 2015
  • Table 5.13 Cyprotex: Historical Revenue ($m), (£m), AGR (%), 2011-2014
  • Table 5.14 Cyprotex: Revenue ($m), Revenue Share (%) by Region, 2015
  • Table 5.15 Cyprotex Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
  • Table 5.16 Cyprotex Selected Collaborations
  • Table 5.17 Evotec: Historical Revenue ($m), 2010-2014
  • Table 5.18 Evotec: Discovery Pipeline, 2016
  • Table 5.19 Evotec Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
  • Table 5.20 GenScript: Services Offered and Descriptions, 2015
  • Table 5.21 Quintiles: Revenue ($bn), AGR (%), 2009-2014
  • Table 5.22 Quintiles Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 5.23 Selcia: Drug Discovery Services Portfolio, 2015
  • Table 5.24 VivaBiotech: Service Offerings, 2015
  • Table 5.25 WuXiAppTec: Pharmaceutical Laboratory Services and Descriptions, 2016
  • Table 5.26 WuXiAppTec: Historical Revenue ($m), AGR (%) by Business Segment, 2010-2014
  • Table 5.27 WuXiAppTec Laboratory Services Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
  • Table 6.1 SWOT Analysis of the Drug Discovery Outsourcing Industry, 2016-2026
  • Table 8.1 The Global Drug Discovery Outsourcing Market Forecast:
  • Revenue ($bn), CAGR (%), 2015, 2020, 2026
  • Table 8.2 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Sector, 2015, 2020, 2026
  • Table 8.3 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Emerging Market, 2015, 2020 and 2026

List of Figures

  • Figure 1.1 The Drug Discovery Outsourcing Market: Overview of Submarkets
  • Figure 2.1Selected Tasks being Outsourced in the Pharma Industry, 2016
  • Figure 2.2 Stages of the Drug Development Cycle
  • Figure 3.1 PhMRA's Historical Estimate for its Member's Total R&D Spending ($bn), 1980-2015
  • Figure 3.2 Attrition Rate of Compounds at the Developmental Stages
  • Figure 3.3 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Sector, 2015
  • Figure 3.4 The Global Drug Discovery Outsourcing Market: Market Share (%) by Sector, 2015
  • Figure 3.5 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 3.6 The Global Drug Discovery Outsourcing Market: Market Shares (%) by Sector, 2020
  • Figure 3.7 The Global Drug Discovery Outsourcing Market: Market Shares (%)by Sector, 2026
  • Figure 3.8 The Chemistry Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 3.9 The Biology Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 3.10 An Overview of ADMET Screening in Drug Discovery
  • Figure 3.11 The Lead Optimisation Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 3.12 Typical Steps in the Lead Screening Process
  • Figure 3.13 The Lead Identification and Screening Outsourcing Market a Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.1 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Region, 2015
  • Figure 4.2 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2015
  • Figure 4.3 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2020
  • Figure 4.4 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2026
  • Figure 4.5 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2015-2020
  • Figure 4.6 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2020-2026
  • Figure 4.7 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2015-2026
  • Figure 4.8 The US Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.9 The EU5 Drug Discovery Outsourcing Market: Market Revenue ($bn) by EU5 Country, 2015
  • Figure 4.10 The EU5 Drug Discovery Outsourcing Market: Market Share (%) by Region, 2015
  • Figure 4.11 The EU5 Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.12 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2015-2020
  • Figure 4.13 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2020-2026
  • Figure 4.14 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2015-2026
  • Figure 4.15 The EU5 Drug Discovery Outsourcing Market Forecast: Market Shares (%) by Country, 2020
  • Figure 4.16 The EU5 Drug Discovery Outsourcing Market Forecast: Market Shares (%) by Country, 2026
  • Figure 4.17 The German Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.18 The UK Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.19 The French Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.20 The Italian Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), 2015-2026
  • Figure 4.21 The Spanish Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.22 The Japanese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.23 The Chinese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.24 The Chinese Population Demographics: Over 65 population and Forecast (millions) , 1950, 2010, 2050
  • Figure 4.25 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.26 The Brazilian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.27 The Russian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.28 The South Korean Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.29 The Mexican Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 4.30 The Rest of the World Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 5.1 Albany Molecular Research (AMRI): Historical Revenue ($m), 2011-2014
  • Figure 5.2 AMRI (DDS) Forecast: Revenue ($m), AGR (%), 2015-2026
  • Figure 5.3 Charles River Laboratories: Revenue ($m), AGR (%), 2011-2014
  • Figure 5.4 Charles River Laboratories: Revenue Share (%) by Segment, 2014
  • Figure 5.5 Charles River Laboratories: Revenue ($bn), 2013-2014
  • Figure 5.6 Charles River Laboratories: Revenue Share (%) by Business Segment, 2014
  • Figure 5.7 Charles River Laboratories Forecast: Revenue ($m), AGR (%), 2015-2026
  • Figure 5.8 Covance: Historical Revenue ($bn), 2010-2013
  • Figure 5.9 Covance: Revenue Share (%) by Segment, 2013
  • Figure 5.10 Cyprotex: Historical Revenue ($m), AGR (%), 2011-2014
  • Figure 5.11 Cyprotex: Revenue Share(%) by Region, 2015
  • Figure 5.12 Cyprotex Forecast: Revenue ($m), AGR (%), 2015-2026
  • Figure 5.13 Domainex: Drug Pipeline by Indication, 2015
  • Figure 5.14 Evotec: Historical Revenue ($m) 2010-2014
  • Figure 5.15 Evotec Forecast: Revenue ($m), AGR (%), 2015-2026
  • Figure 5.16 Quintiles: Historical Revenue ($bn), AGR (%), 2009-2014
  • Figure 5.17 Quintiles Forecast: Revenue ($bn), AGR (%), 2015-2026
  • Figure 5.18 WuXiAppTec: Historical Revenue ($m) for Laboratory Services, 2010-2014
  • Figure 5.19 WuXiAppTec Laboratory Services Forecast: Revenue ($m), AGR (%), 2015-2026
  • Figure 6.1 The Drug Discovery Outsourcing Market: Drivers and Restraints, 2016-2026
  • Figure 6.2 Porter's Five Analysis of the Companion Diagnostics Market, 2016-2026
  • Figure 8.1 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), 2015, 2020, 2026
  • Figure 8.2 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Sector, 2015, 2020, 2026
  • Figure 8.3 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Emerging Market, 2015, 2020 and 2026

Companies Listed

  • AbbVie
  • Actavis
  • Acurian
  • Advion Bioanalytical Labs
  • Albany Molecular Research (AMRI)
  • Apredica
  • Aptuit
  • Argenta
  • Ark Therapeutics
  • Astex
  • AstraZeneca
  • Auspherix
  • Bayer
  • Behrman Capital
  • Beijing Genomics Institute
  • BioCity
  • Bio Pontis Alliance
  • BioDuro
  • BioFocus
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Cantab
  • CaprionProteomics
  • Carlyle Group
  • Catalent
  • ChanTest
  • Charles River Laboratories
  • CHDI
  • CHDI Foundation
  • CONBA
  • Covance
  • Cyprotex
  • Domainex
  • Elan
  • Eli Lilly
  • Evotec
  • Exquiron Biotech
  • Forma Therapeutics
  • Galapagos
  • Genentech
  • GenScript
  • GlaxoSmithKline
  • Great Lakes Chemical Corp
  • Harvard
  • Horizon
  • Hypha Discovery
  • IMI
  • Janssen Pharmaceutical
  • JingXin
  • Johnson & Johnson
  • Kellogg Company
  • Keucept
  • Knopp Biosciences
  • Laboratory Corporation of America
  • Laurus Labs
  • MedImmune
  • Merck
  • Midwest Bio Research
  • Milner Therapeutics Institute and Consortium
  • MIT
  • Next CODE Health
  • Parexel
  • Pharmaceutical Product Development (PPD)
  • PhRMA (Pharmaceutical Research and Manufacturers of America)
  • National Institutes of Health
  • Ono
  • Proteros Biostructures
  • Quintile
  • Roche
  • Sanofi
  • Selcia
  • Shionogi
  • Siena Biotech
  • The Babraham Institute
  • The Sanger Institute
  • UCB
  • University of Cambridge
  • University of Edinburgh
  • Viva Biotech
  • Vivo Path
  • WIL Research Laboratories
  • WuXi AppTec
  • WuXi PharmaTech
Back to Top